Herlev Hospital is a hospital in Herlev, Denmark, close to Copenhagen. The building is 120 metres tall and has 25 floors. It is famous for being Denmark's tallest building. Its modern, functional architecture in bright concrete, glass and bronze-colored aluminum gives a unique impression.

During the past decade, Department of Hematology, Herlev Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Hematology, Herlev Hospital" #1 sponsor was "Inge Marie Svane" with 7 trials, followed by "Henrik Gregersen" with 2 trials sponsored, "Nordic MDS Group" with 2 trials sponsored, "Daniel El Fassi" with 1 trials sponsored and "Herlev Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Herlev Hospital" #1 collaborator was "Danish Myeloma Study Group" with 2 trials as a collaborator and "Technical University of Denmark" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology, Herlev Hospital" are "Essential Thrombocythemia" (2 trials), "Malignant Melanoma" (2 trials), "Metastatic Melanoma" (2 trials), "Metastatic Ovarian Cancer" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Department of Hematology, Herlev Hospital" in a lesser frequency.

Most popular intervention types in "Department of Hematology, Herlev Hospital" are "Drug" (13 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Interleukin-2" (3 trials), "TIL infusion" (3 trials), "Azacitidine" (2 trials) and "Clarithromycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology, Herlev Hospital" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Hematology, Herlev Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Department of Hematology, Herlev Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology, Herlev Hospital, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".